Log in
Enquire now
‌

US Patent 11464734 Methods of treating overactive bladder using trospium

Patent 11464734 was granted and assigned to TARIS Biomedical on October, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
TARIS Biomedical
TARIS Biomedical
0
Current Assignee
TARIS Biomedical
TARIS Biomedical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114647340
Patent Inventor Names
Dennis Giesing0
Date of Patent
October 11, 2022
0
Patent Application Number
165280320
Date Filed
July 31, 2019
0
Patent Citations
‌
US Patent 10500200 Drug delivery systems and methods for treatment of bladder dysfunction or disorder using trospium
0
Patent Citations Received
‌
US Patent 12133913 Methods of treating overactive bladder using trospium
0
Patent Primary Examiner
‌
Sahar Javanmard
0
CPC Code
‌
A61P 13/06
0
‌
A61M 2210/1085
0
‌
A61K 31/46
0
‌
A61K 9/0034
0
‌
A61K 31/439
0
‌
A61P 13/10
0

The present application provides methods of treating overactive bladder and methods of training or retraining bladder, prolonging symptom relief, improving the quality of life and/or neuronal remodeling in an individual having overactive bladder, by administering an effective amount of trospium locally to the bladder of the individual for at least about 24 hours.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11464734 Methods of treating overactive bladder using trospium

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.